{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:42:25Z","timestamp":1761766945772,"version":"build-2065373602"},"reference-count":125,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cll.2021.03.018","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T08:58:45Z","timestamp":1625129925000},"page":"359-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Update on Pediatric and Young Adult Mature Lymphomas"],"prefix":"10.1016","volume":"41","author":[{"given":"Emily F.","family":"Mason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra E.","family":"Kovach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.cll.2021.03.018_bib1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","article-title":"Non-Hodgkin's lymphoma in childhood","volume":"334","author":"Sandlund","year":"1996","journal-title":"N\u00a0Engl J Med"},{"year":"2017","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","key":"10.1016\/j.cll.2021.03.018_bib2"},{"issue":"6","key":"10.1016\/j.cll.2021.03.018_bib3","first-page":"1063","article-title":"The pathology and nomenclature of Hodgkin's disease","volume":"26","author":"Lukes","year":"1966","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.cll.2021.03.018_bib4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A\u00a0revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2021.03.018_bib5","first-page":"1889","article-title":"European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes","volume":"96","author":"Anagnostopoulos","year":"2000","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cll.2021.03.018_bib6","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3109\/10428194.2010.525724","article-title":"Comparing adult and pediatric hodgkin lymphoma in the Surveillance, Epidemiology and End results Program, 1988-2005: an analysis of 21 734 cases","volume":"51","author":"Bazzeh","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bjh.12244","article-title":"Modern management of lymphocyte-predominant Hodgkin lymphoma","volume":"161","author":"Xing","year":"2013","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.cll.2021.03.018_bib8","first-page":"1294","article-title":"Follicular Hodgkin's disease","volume":"19","author":"Ashton-Key","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib9","first-page":"242","article-title":"Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies","volume":"36","author":"Chan","year":"1999","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease","volume":"17","author":"Diehl","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bjh.15616","article-title":"Modern principles in the management of nodular lymphocyte-predominant Hodgkin lymphoma","volume":"184","author":"Spinner","year":"2019","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.cll.2021.03.018_bib12","first-page":"135","article-title":"Progressive transformation of germinal centers: comparison of 23 pediatric patients to the adult population","volume":"5","author":"Osborne","year":"1992","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pbc.24296","article-title":"A\u00a0pediatric translational perspective on the entity \"progressive transformation of germinal centers (PTGC)\"","volume":"60","author":"Miles","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1016\/j.cll.2021.03.018_bib14","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26753","article-title":"Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: a report from the Children's Oncology Group","volume":"65","author":"Untanu","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","article-title":"EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults","volume":"38","author":"Huppmann","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.cll.2021.03.018_bib17","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/sj.leu.2404736","article-title":"Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma","volume":"21","author":"Stamatoullas","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.cll.2021.03.018_bib18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2002-05-1592","article-title":"Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma","volume":"101","author":"Wlodarska","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3324\/haematol.2009.010157","article-title":"Mutations in the genes coding for the NF-kappaB regulating factors IkappaBalpha and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma","volume":"95","author":"Schumacher","year":"2010","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.cll.2021.03.018_bib20","doi-asserted-by":"crossref","first-page":"e78812","DOI":"10.1371\/journal.pone.0078812","article-title":"Nodular lymphocyte predominant hodgkin lymphoma and T\u00a0cell\/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?","volume":"8","author":"Hartmann","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cll.2021.03.018_bib21","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjh.15734","article-title":"Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies","volume":"185","author":"Egan","year":"2019","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/asheducation-2016.1.589","article-title":"Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum","volume":"2016","author":"Sandlund","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/pbc.22047","article-title":"Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005","volume":"53","author":"Mbulaiteye","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.cll.2021.03.018_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1309\/77V7U4E03V69QHRR","article-title":"TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma","volume":"124","author":"Teitell","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.cll.2021.03.018_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/bjh.13624","article-title":"Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue","volume":"171","author":"Masque-Soler","year":"2015","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.cll.2021.03.018_bib26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3324\/haematol.2016.156885","article-title":"Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Munster protocols","volume":"102","author":"Rohde","year":"2017","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.cll.2021.03.018_bib27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.cll.2021.03.018_bib28","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2021.03.018_bib29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/bjh.13969","article-title":"Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children","volume":"173","author":"Giulino-Roth","year":"2016","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.cll.2021.03.018_bib30","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A\u00a0recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cll.2021.03.018_bib31","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Gonzalez-Farre","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.cll.2021.03.018_bib32","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/modpathol.2017.186","article-title":"A\u00a0comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration","volume":"31","author":"Rymkiewicz","year":"2018","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.cll.2021.03.018_bib33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.16578","article-title":"Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group","volume":"190","author":"Au-Yeung","year":"2020","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.cll.2021.03.018_bib34","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2021.03.018_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/bjh.14074","article-title":"Adolescent and young adult non-Hodgkin lymphoma","volume":"173","author":"Hochberg","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.cll.2021.03.018_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.seminoncol.2009.07.009","article-title":"Lymphoma in adolescents and young adults","volume":"36","author":"Jaglowski","year":"2009","journal-title":"Semin Oncol"},{"issue":"10","key":"10.1016\/j.cll.2021.03.018_bib38","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2005-10-4213","article-title":"Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial","volume":"107","author":"Oschlies","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjh.14812","article-title":"Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents","volume":"179","author":"Szczepanowski","year":"2017","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pbc.21619","article-title":"Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: report of the French-American-British (FAB) international study group","volume":"51","author":"Miles","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"27","key":"10.1016\/j.cll.2021.03.018_bib42","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2014.59.5827","article-title":"Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead","volume":"33","author":"Minard-Colin","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.cll.2021.03.018_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/leu.2008.312","article-title":"Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB\/LMB 96 international study","volume":"23","author":"Poirel","year":"2009","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.cll.2021.03.018_bib44","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1182\/blood-2011-05-349662","article-title":"Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling","volume":"119","author":"Deffenbacher","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2021.03.018_bib45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cll.2021.03.018_bib46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.clml.2011.07.003","article-title":"EBV-positive diffuse large b-cell lymphoma in young immunocompetent individuals","volume":"11","author":"Beltran","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"10.1016\/j.cll.2021.03.018_bib47","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/ijc.27845","article-title":"Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment","volume":"132","author":"Cohen","year":"2013","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.cll.2021.03.018_bib48","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/ijc.28942","article-title":"Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients","volume":"135","author":"Cohen","year":"2014","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib49","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/annonc\/mdu556","article-title":"EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?","volume":"26","author":"Hong","year":"2015","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.cll.2021.03.018_bib50","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.humpath.2015.01.011","article-title":"Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly","volume":"46","author":"Uccini","year":"2015","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.cll.2021.03.018_bib51","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.cll.2021.03.018_bib52","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.cll.2021.03.018_bib53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/gcc.22249","article-title":"Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma","volume":"54","author":"Yoon","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAS.0b013e31826b9b57","article-title":"Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.cll.2021.03.018_bib56","doi-asserted-by":"crossref","first-page":"e27770","DOI":"10.1002\/pbc.27770","article-title":"IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials","volume":"66","author":"Chisholm","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.cll.2021.03.018_bib57","doi-asserted-by":"crossref","first-page":"e28416","DOI":"10.1002\/pbc.28416","article-title":"Rare non-Hodgkin lymphoma of childhood and adolescence: a consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma","volume":"67","author":"Attarbaschi","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.cll.2021.03.018_bib58","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.V99.6.1959","article-title":"Clinicopathologic analysis of follicular lymphoma occurring in children","volume":"99","author":"Lorsbach","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2021.03.018_bib59","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3324\/haematol.2009.013177","article-title":"Pediatric follicular lymphoma--a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma--Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials","volume":"95","author":"Oschlies","year":"2010","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.cll.2021.03.018_bib60","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2012.073916","article-title":"Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas","volume":"98","author":"Martin-Guerrero","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.cll.2021.03.018_bib61","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","article-title":"Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations","volume":"128","author":"Louissaint","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cll.2021.03.018_bib62","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00277-013-1785-2","article-title":"Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a \"Watch and wait\" strategy after complete resection","volume":"92","author":"Attarbaschi","year":"2013","journal-title":"Ann Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2021.03.018_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hon.2585","article-title":"Rare mature B-cell lymphomas in children and adolescents","volume":"37","author":"Woessmann","year":"2019","journal-title":"Hematol Oncol"},{"issue":"12","key":"10.1016\/j.cll.2021.03.018_bib64","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2012-05-429514","article-title":"Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement","volume":"120","author":"Louissaint","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cll.2021.03.018_bib65","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00428-019-02681-y","article-title":"Novel markers in pediatric-type follicular lymphoma","volume":"475","author":"Agostinelli","year":"2019","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.cll.2021.03.018_bib66","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bjh.14868","article-title":"Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma","volume":"182","author":"Makarova","year":"2018","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.cll.2021.03.018_bib67","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/modpathol.2010.63","article-title":"Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR","volume":"23","author":"Rizzo","year":"2010","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.cll.2021.03.018_bib68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00428-015-1855-z","article-title":"Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4\/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia","volume":"468","author":"Quintanilla-Martinez","year":"2016","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.cll.2021.03.018_bib69","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000478-200304000-00014","article-title":"Marginal zone B-cell lymphoma in children and young adults","volume":"27","author":"Taddesse-Heath","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"Suppl","key":"10.1016\/j.cll.2021.03.018_bib70","first-page":"S98","article-title":"Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia","volume":"122","author":"Swerdlow","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.cll.2021.03.018_bib71","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/modpathol.2016.102","article-title":"A\u00a0study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma","volume":"29","author":"Ozawa","year":"2016","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib72","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/path.4524","article-title":"Paediatric nodal marginal zone B-cell lymphadenopathy of the neck: a Haemophilus influenzae-driven immune disorder?","volume":"236","author":"Kluin","year":"2015","journal-title":"J\u00a0Pathol"},{"issue":"Suppl","key":"10.1016\/j.cll.2021.03.018_bib73","first-page":"S110","article-title":"Mature T-cell and NK-cell lymphomas in the pediatric age group","volume":"122","author":"Jaffe","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.cll.2021.03.018_bib74","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/bjh.14044","article-title":"Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents","volume":"173","author":"Pillai","year":"2016","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.cll.2021.03.018_bib75","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/pbc.21293","article-title":"Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20 years","volume":"50","author":"Windsor","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.cll.2021.03.018_bib76","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/MPH.0b013e3182707592","article-title":"Peripheral T-cell lymphoma in children and adolescents: a single-institution experience","volume":"34","author":"Al Mahmoud","year":"2012","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"8","key":"10.1016\/j.cll.2021.03.018_bib77","doi-asserted-by":"crossref","first-page":"e27798","DOI":"10.1002\/pbc.27798","article-title":"A\u00a0clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: a single tertiary care pediatric institution experience in North America","volume":"66","author":"Coffey","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.cll.2021.03.018_bib78","first-page":"4991","article-title":"Clinicopathological characteristics of four cases of EBV positive T-cell lymphoproliferative disorders of childhood in China","volume":"7","author":"Huang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"10.1016\/j.cll.2021.03.018_bib79","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2021.03.018_bib80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/cancers10040099","article-title":"Treatment options for paediatric anaplastic large cell lymphoma (ALCL): current standard and beyond","volume":"10","author":"Prokoph","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib81","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.cll.2021.03.018_bib82","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2006-06-028969","article-title":"Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes","volume":"109","author":"Lamant","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cll.2021.03.018_bib83","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib84","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/bjh.15860","article-title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma","volume":"186","author":"Hapgood","year":"2019","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.cll.2021.03.018_bib85","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10428194.2015.1064530","article-title":"Genetics of anaplastic large cell lymphoma","volume":"57","author":"Zeng","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib87","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0002-9440(10)65629-5","article-title":"ALK expression defines a distinct group of T\/null lymphomas (\"ALK lymphomas\") with a wide morphological spectrum","volume":"153","author":"Falini","year":"1998","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.cll.2021.03.018_bib88","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: a single disease with a broad spectrum of morphology","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cll.2021.03.018_bib89","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00000478-199010000-00013","article-title":"Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma","volume":"14","author":"Chan","year":"1990","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.cll.2021.03.018_bib90","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199309000-00001","article-title":"A\u00a0small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma","volume":"17","author":"Kinney","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"35","key":"10.1016\/j.cll.2021.03.018_bib91","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1200\/JCO.2011.36.5411","article-title":"Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study","volume":"29","author":"Lamant","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.cll.2021.03.018_bib93","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/bjh.13958","article-title":"Anaplastic large cell lymphoma in paediatric and young adult patients","volume":"173","author":"Turner","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib94","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12885-018-4042-1","article-title":"Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol","volume":"18","author":"Sekimizu","year":"2018","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.cll.2021.03.018_bib95","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3324\/haematol.2013.085837","article-title":"Expression of CD8 is associated with non-common type morphology and outcome in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma","volume":"98","author":"Abramov","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.cll.2021.03.018_bib96","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2007.06924.x","article-title":"Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas","volume":"140","author":"Salaverria","year":"2008","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.cll.2021.03.018_bib97","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.humpath.2005.03.004","article-title":"Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas","volume":"36","author":"Thompson","year":"2005","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.cll.2021.03.018_bib98","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1309\/FNY8Y4H6PK1V2MGE","article-title":"Expression of anaplastic lymphoma kinase, tyrosine-phosphorylated STAT3, and associated factors in pediatric anaplastic large cell lymphoma: a report from the children's oncology group","volume":"127","author":"Nasr","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1008352726155","article-title":"Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric Oncology","volume":"11","author":"Brugieres","year":"2000","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.cll.2021.03.018_bib100","first-page":"2697","article-title":"ALK+ lymphoma: clinico-pathological findings and outcome","volume":"93","author":"Falini","year":"1999","journal-title":"Blood"},{"issue":"41","key":"10.1016\/j.cll.2021.03.018_bib101","doi-asserted-by":"crossref","first-page":"26543","DOI":"10.18632\/oncotarget.25489","article-title":"Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphoma","volume":"9","author":"Krumbholz","year":"2018","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.cll.2021.03.018_bib102","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00277-016-2722-y","article-title":"Non-anaplastic peripheral T\u00a0cell lymphoma in children and adolescents-an international review of 143 cases","volume":"95","author":"Mellgren","year":"2016","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib103","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajh.21903","article-title":"Malignancies in the setting of primary immunodeficiency: implications for hematologists\/oncologists","volume":"86","author":"Shapiro","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cll.2021.03.018_bib104","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.3389\/fimmu.2018.03136","article-title":"Primary immunodeficiency and cancer Predisposition Revisited: Embedding two Closely related Concepts into an Integrative conceptual Framework","volume":"9","author":"Haas","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.cll.2021.03.018_bib105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjh.13216","article-title":"Non-anaplastic peripheral T-cell lymphoma in children and adolescents--a retrospective analysis of the NHL-BFM study group","volume":"168","author":"Kontny","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib106","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pbc.21543","article-title":"Non-anaplastic peripheral t-cell lymphoma in childhood and adolescence: a Children's Oncology Group study","volume":"51","author":"Hutchison","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"16","key":"10.1016\/j.cll.2021.03.018_bib107","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.cll.2021.03.018_bib108","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.12251","article-title":"Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology","volume":"64","author":"Attygalle","year":"2014","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.cll.2021.03.018_bib109","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/PAS.0b013e31822832de","article-title":"Nodular lymphocyte-predominant hodgkin lymphoma with atypical T\u00a0cells: a morphologic variant mimicking peripheral T-cell lymphoma","volume":"35","author":"Sohani","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cyto.b.20071","article-title":"Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group","volume":"68","author":"Borowitz","year":"2005","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"10.1016\/j.cll.2021.03.018_bib111","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/blood.V67.2.474.474","article-title":"Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T\u00a0cell acute lymphoblastic leukemia","volume":"67","author":"Weiss","year":"1986","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2021.03.018_bib112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.leu.2403559","article-title":"Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection","volume":"19","author":"Gaipa","year":"2005","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib113","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cyto.b.20511","article-title":"Immaturity associated antigens are lost during induction for T\u00a0cell lymphoblastic leukemia: implications for minimal residual disease detection","volume":"78","author":"Roshal","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"issue":"19","key":"10.1016\/j.cll.2021.03.018_bib114","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.cll.2021.03.018_bib115","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.cll.2021.03.018_bib116","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cll.2021.03.018_bib117","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.cll.2021.03.018_bib118","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib119","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.cll.2021.03.018_bib120","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.leu.2400742","article-title":"Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T\u00a0cell lymphoma","volume":"11","author":"Alonsozana","year":"1997","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.cll.2021.03.018_bib121","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/gcc.10021","article-title":"Fluorescence in\u00a0situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression","volume":"33","author":"Wlodarska","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"10.1016\/j.cll.2021.03.018_bib122","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/leu.2014.200","article-title":"Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas","volume":"28","author":"Nicolae","year":"2014","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.cll.2021.03.018_bib123","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.cll.2021.03.018_bib124","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/MEG.0b013e32834bb90a","article-title":"Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor therapy: expanding the groups at risk","volume":"23","author":"Parakkal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"21","key":"10.1016\/j.cll.2021.03.018_bib125","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2018-03-842088","article-title":"IG-MYC (+) neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas","volume":"132","author":"Wagener","year":"2018","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cll.2021.03.018_bib126","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.5858\/arpa.2018-0208-RA","article-title":"Epstein-barr virus hepatitis: a review of clinicopathologic features and differential diagnosis","volume":"142","author":"Schechter","year":"2018","journal-title":"Arch Pathol Lab Med"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271221000184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271221000184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:57:13Z","timestamp":1759449433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271221000184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":125,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0272271221000184"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2021.03.018","relation":{},"ISSN":["0272-2712"],"issn-type":[{"type":"print","value":"0272-2712"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Pediatric and Young Adult Mature Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2021.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}